Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

Q: What does CUSIP 09203E105 represent in this 13F holders report?

CUSIP 09203E105 is the security identifier for BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2024?

95 institutional investors reported BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 09203E105

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 58,000,000
Total 13F shares: 48,717,118
Share change: +629,160
Total reported value: $211,892,256
Put/Call ratio: 144%
Reported price per share: $4.35
Number of holders: 95
Value change: +$1,570,817
Number of buys: 57
Number of sells: 37

Security key

09203E105

Report period

Q3 2024

Institutions

Top holders

BDTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Black Diamond Therapeutics, Inc. SEC filings Black Diamond Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 09203E105

Newer quarter: Q4 2024 Previous quarter: Q2 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

T. Rowe Price Investment ...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2024

13F Lead comparable stake: 18% Showing 1-6 of 15 holder rows.

Rank 1 holder

T. Rowe Price Investment Management, Inc.

13F

Ownership: 18%
Position: $49.68M

13F

Rank 2 holder

Bellevue Group AG

13F

Ownership: 15%
Position: $39.69M

13F

Rank 3 holder

NEA Management Company, LLC

13F

Ownership: 7.7%
Position: $20.73M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
T. Rowe Price Investment Management, Inc.	13F Company 13F	18%	$49,675,000 10,659,730 shares	—	30 Jun 2024
Bellevue Group AG	13F Company 13F	15%	$39,693,130 8,517,839 shares	—	30 Jun 2024
NEA Management Company, LLC	13F Company 13F	7.7%	$20,731,208 4,448,757 shares	—	30 Jun 2024
BlackRock Finance, Inc.	13F Company 13F	5.5%	$14,991,815 3,217,128 shares	—	30 Jun 2024
VANGUARD GROUP INC	13F Company 13F	3.7%	$9,933,367 2,131,624 shares	—	30 Jun 2024
Vestal Point Capital, LP	13F Company 13F	3.6%	$9,786,000 2,100,000 shares	—	30 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

48,717,118

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend